BD (Becton, Dickinson and Company) has announced the initiation of a patient data registry for the Rotarex™ Atherectomy System, aimed at assessing real-world outcomes in the treatment of peripheral artery disease (PAD). Known as the "XTRACT Registry," this study will evaluate the clinical performance of the system in U.S. patients with PAD lesions. The registry is a prospective, multi-center, single-arm, post-market study, expected to enroll up to 600 patients across approximately 100 clinical sites in the United States. Co-Principal Investigators Dr. Prakash Krishnan and Dr. Todd Berland will lead the study, with patient follow-ups scheduled at 30 days, 6 months, and 12 months post-procedure to assess safety and effectiveness. The Rotarex™ Atherectomy System is a minimally invasive device designed for removing plaque and thrombus in peripheral arteries, with dual indications as both an atherectomy and thrombectomy tool.